首页> 外文期刊>American pharmaceutical review >Understanding Infrared and Raman Spectra of Pharmaceutical Polymorphs
【24h】

Understanding Infrared and Raman Spectra of Pharmaceutical Polymorphs

机译:了解药物多晶型物的红外光谱和拉曼光谱

获取原文
获取原文并翻译 | 示例
       

摘要

Infrared and Raman spectra of different crystalline forms of the same organic compound can be used to identify a pure crystal form and quantify a mixture of two forms. Many organic compounds have one or more crystalline or polymorphic forms. The observed differences in the spectra of different polymorphs include changes in frequencies, relative intensities, band contours and the number of bands. Causes of the spectral differences can be interpreted in terms of molecule-molecule interactions in the crystal unit cells. Molecular interactions can distort the shape of a molecule at its site in the unit cell. Moreover, vibrations of one or more molecules can couple in such a way as to increase the number of bands and shift their frequencies. Herein, spectral changes are explained using a hypothetical three-atom molecule and a real five-atom molecule. Finally, the differences in spectra of large molecules are demonstrated with polymorphs of three active pharmaceutical ingredients (API).
机译:相同有机化合物的不同晶体形式的红外和拉曼光谱可用于鉴定纯晶体形式并定量两种形式的混合物。许多有机化合物具有一种或多种结晶或多晶型形式。观察到的不同多晶型物的光谱差异包括频率,相对强度,能带轮廓和能带数量的变化。光谱差异的原因可以用晶体晶胞中的分子-分子相互作用来解释。分子相互作用可以使单位细胞中分子的形状变形。而且,一个或多个分子的振动可以以增加带的数量并改变其频率的方式耦合。在此,使用假设的三原子分子和真实的五原子分子来解释光谱变化。最后,用三种活性药物成分(API)的多晶型物证明了大分子光谱的差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号